Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders

Nakamura, 1978, Recent progress in the study of autoantibodies to nuclear antigens, Hum Pathol, 9, 85, 10.1016/S0046-8177(78)80010-0 Burnham, 1966, The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses, Ann Intern Med, 65, 9, 10.7326/0003-4819-65-1-9 Notman, 1975, Profiles of antinuclear anti-bodies in systemic rheumatic diseases, Ann Intern Med, 83, 464, 10.7326/0003-4819-83-4-464 Northway, 1972, Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence, Clin Immunol Immunopathol, 1, 140, 10.1016/0090-1229(72)90013-X Bernstein, 1982, Association of anti-nuclear and antinucleolar antibodies in progressive systemic sclerosis, Clin Exp Immunol, 48, 43 Tuffanelli, 1983, Anticentromere and anticentriole antibodies in the scleroderma spectrum, Arch Dermatol, 119, 560, 10.1001/archderm.1983.01650310022004 Moroi, 1980, Autoantibody to centromere (kinetochore) in scleroderma sera, 77, 1627 Kleinsmith, 1982, Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma, Arch Dermatol, 118, 882, 10.1001/archderm.1982.01650230010017 Korn, 1979, Scleroderma (systemic sclerosis), vol 4, 249 Kahaleh, 1979, Endothelial injury in scleroderma, J Exp Med, 149, 1326, 10.1084/jem.149.6.1326 Maricq, 1980, Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders, Arthritis Rheum, 23, 183, 10.1002/art.1780230208 Maricq, 1980, Predictive value of capillary microscopy in patients with Raynaud's phenomenon (abstr), Arthritis Rheum, 23, 716 Maricq, 1982, Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy; a prospective study of patients with Raynaud's phenomenon, J Rheumatol, 9, 289 Harper, 1982, A prospective study of Raynaud phenomenon and early connective tissue disease: a five-year report, Am J Med, 72, 883, 10.1016/0002-9343(82)90846-4 Maricq, 1982, The microcirculation in scleroderma and allied diseases, Adv Microcirc, 10, 17 Maricq, 1983, Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease, Clin Exp Rheumatol, 1, 195 Cohen, 1971, Preliminary criteria for the classification of systemic lupus erythematosus, Bull Rheum Dis, 21, 643 Tan, 1980, Diversity of antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome, Arthritis Rheum, 23, 617, 10.1002/art.1780230602 Fritzler, 1980, The CREST syndrome: a distinct serologic entity with anticentromere antibodies, Am J Med, 69, 520, 10.1016/0002-9343(80)90462-3 Maricq, 1981, Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders, Arthritis Rheum, 24, 1159, 10.1002/art.1780240907 Beck, 1963, Antinuclear and precipitating autoantibodies in progressive systemic sclerosis, Lancet, II, 1188, 10.1016/S0140-6736(63)92920-9 Rothfield, 1968, Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma), Arthritis Rheum, 11, 607, 10.1002/art.1780110502 Burnham, 1974, Antinuclear antibodies I. Patterns of nuclear immunofluorescence, J Invest Dermatol, 62, 526, 10.1111/1523-1747.ep12681110 Tan, 1981, Antinuclear antibodies in scleroderma, Int J Dermatol, 20, 569, 10.1111/j.1365-4362.1981.tb00835.x Cattogio, 1983, Serological markers in progressive systemic sclerosis: clinical correlations, Ann Rheum Dis, 42, 23, 10.1136/ard.42.1.23 McCarty, 1983, Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants, Arthritis Rheum, 26, 1, 10.1002/art.1780260101